APA (7th ed.) Citation

Huseni, M., Totpal, K., Du, C., Dalpozzo, K., Zhu, J., Rishipathak, D., . . . Kim, J. (2014). Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models. Journal for immunotherapy of cancer, 2(Suppl 3), P253. https://doi.org/10.1186/2051-1426-2-S3-P253

Chicago Style (17th ed.) Citation

Huseni, Mahrukh, et al. "Anti-tumor Efficacy and Biomarker Evaluation of Agonistic Anti-OX40 Antibodies in Preclinical Models." Journal for Immunotherapy of Cancer 2, no. Suppl 3 (2014): P253. https://doi.org/10.1186/2051-1426-2-S3-P253.

MLA (9th ed.) Citation

Huseni, Mahrukh, et al. "Anti-tumor Efficacy and Biomarker Evaluation of Agonistic Anti-OX40 Antibodies in Preclinical Models." Journal for Immunotherapy of Cancer, vol. 2, no. Suppl 3, 2014, p. P253, https://doi.org/10.1186/2051-1426-2-S3-P253.